Inactivating TDP2 missense mutation in siblings with congenital abnormalities reminiscent of fanconi anemia

[1]  E. Noguchi,et al.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair , 2022, Human Genetics.

[2]  N. Willis,et al.  The structure-specific endonuclease complex SLX4–XPF regulates Tus–Ter-induced homologous recombination , 2021, Nature Structural & Molecular Biology.

[3]  Hossein Jafari Khamirani,et al.  A novel non-sense mutation in TDP2 causes spinocerebellar ataxia autosomal recessive 23 accompanied by bilateral upward gaze; report of a case and review of the literature. , 2021, European journal of medical genetics.

[4]  L. Garavelli,et al.  Characterization of a novel loss-of-function variant in TDP2 in two adult patients with spinocerebellar ataxia autosomal recessive 23 (SCAR23) , 2020, Journal of Human Genetics.

[5]  C. Romano,et al.  Consolidating the Role of TDP2 Mutations in Recessive Spinocerebellar Ataxia Associated with Pediatric Onset Drug Resistant Epilepsy and Intellectual Disability (SCAR23) , 2019, The Cerebellum.

[6]  A. Bradley,et al.  ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks , 2019, Nature Communications.

[7]  Robert W. Taylor,et al.  Confirming TDP2 mutation in spinocerebellar ataxia autosomal recessive 23 (SCAR23) , 2018, Neurology: Genetics.

[8]  Fengtang Yang,et al.  ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks , 2018, bioRxiv.

[9]  Ioanna Ntai,et al.  TDP2 suppresses chromosomal translocations induced by DNA topoisomerase II during gene transcription , 2017, Nature Communications.

[10]  L. Perera,et al.  Reversal of DNA damage induced Topoisomerase 2 DNA–protein crosslinks by Tdp2 , 2016, Nucleic acids research.

[11]  J. Schuurs-Hoeijmakers,et al.  TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function , 2014, Nature Genetics.

[12]  K. Caldecott,et al.  Generation of assays and antibodies to facilitate the study of human 5'-tyrosyl DNA phosphodiesterase. , 2013, Analytical biochemistry.

[13]  D. Huylebroeck,et al.  TDP2–Dependent Non-Homologous End-Joining Protects against Topoisomerase II–Induced DNA Breaks and Genome Instability in Cells and In Vivo , 2013, PLoS genetics.

[14]  K. Caldecott.  Tyrosyl DNA phosphodiesterase 2, an enzyme fit for purpose , 2012, Nature Structural &Molecular Biology.

[15]  D. Ramsden,et al.  Mechanism of 5′ Topoisomerase II DNA adduct repair by mammalian Tyrosyl DNA phosphodiesterase 2 (Tdp2) , 2012, Nature Structural &Molecular Biology.

[16]  J. Dahm-Daphi,et al.  FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons. , 2011, Cancer letters.

[17]  Z. Zeng,et al.  TDP2/TTRAP Is the Major 5′-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II-induced DNA Damage , 2010, The Journal of Biological Chemistry.

[18]  K. Caldecott,et al.  A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage , 2009, Nature.

[19]  B. Novák,et al.  Supplementary Fig. 1 , 2021 .

[20]  Robert W. Taylor,et al.  Con fi rming TDP 2 mutation in spinocerebellar ataxia autosomal recessive 23 ( SCAR 23 ) , 2019 .

[21]  Yves,et al.  Structural basis for recognition of 5 ′-phosphotyrosine adducts by TDP 2 , 2013 .